Cigna Corporation

NYSE:CI

Medical - Healthcare Plans

Healthcare
$285.37 -1.56%

-$4.44 today

Market cap
$75.20B
Beta
0.30
P/E (TTM)
11.7
EPS (TTM)
$23.95
Dividend yield
2.19%
52W Low $239.51High $338.89

Volume 2.49M

Average 1.61M

CI Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Cigna CorporationNYSE: CI

Gross Margin · Q3 FY2026 · quarter ended Sep 2026

Gross margin narrows to 3.3%

Gross margin was 3.3% in Q3 FY2026, down 5.3 pp from a year earlier. On a trailing-twelve-month basis it was 10.3%, up 0.2 pp year over year. Over 3 fiscal years it narrowed by 3.6 pp.

Context

  • Gross margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
3.3%-17.6 pp QoQ
Last fiscal yearDec 2025
9.5%-1.1 pp YoY
LTMSep 2026
10.3%+0.2 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-5.3 pp——
1 year-1.1 pp——
3 years-3.6 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
9.5%
Year-over-year change
-1.1pp

Gross Margin vs competitors

How CI compares with its peers on the latest reported figures

  • CI's LTM Sep 2026 gross margin of 10.3% is the 8th highest of the 9 companies compared; the peer median is 15.1%.
  • Its year-over-year change of +0.2 pp is the 7th highest of 9, against a peer median of +2.0 pp.
  • Over three fiscal years its change of -3.6 pp compares with a peer median of -3.2 pp.
CI Competitors Peer median
Gross Margin for CI and competitors
Company Period LTM level YoY 3-year change
OSCROscar Health, Inc.LTM Jun 202644.9% +9.0 pp-85.6 pp
ELVElevance Health Inc.LTM Sep 202636.6% +10.3 pp+0.0 pp
UNHUnitedHealth Group IncorporatedLTM Sep 202622.8% +3.1 pp-6.0 pp
CNCCentene CorporationLTM Jun 202616.1% +7.2 pp+0.7 pp
CVSCVS Health CorporationLTM Jun 202614.2% +0.3 pp-3.1 pp
HUMHumana Inc.LTM Sep 202613.0% -1.9 pp-4.0 pp
ALHCAlignment Healthcare, Inc.LTM Mar 202612.4% +0.8 pp-0.5 pp
CICigna CorporationLTM Sep 202610.3% +0.2 pp-3.6 pp
MOHMolina Healthcare, Inc.LTM Sep 20268.1% -2.0 pp-3.3 pp
Peer median (excluding CI) 15.1%+2.0 pp-3.2 pp

Competitors are the stored peer set for CI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue174.07B180.52B195.27B247.12B274.95B
Cost of Revenue151.12B157.02B170.09B221.16B248.97B
Gross Profit22.95B23.5B25.18B25.96B25.99B
Gross Margin13.2%13.0%12.9%10.5%9.5%
Research & Development00000
Selling, General & Admin12.79B13.05B14.32B14.57B14B
Operating Expenses15.01B15.05B16.64B16.55B16.86B
Depreciation & Amortization2.92B2.94B3.04B2.78B2.78B
EBITDA11.09B11.52B12.07B12.47B11.75B
EBITDA Margin6.4%6.4%6.2%5.0%4.3%
Operating Income7.94B8.45B8.54B9.42B9.13B
Operating Margin4.6%4.7%4.4%3.8%3.3%
Interest Income00000
Interest Expense1.21B1.23B1.45B1.44B1.38B
Other Income / Expenses(1.15B)(53M)(3.02B)(4.15B)(1.54B)
Income Before Tax6.79B8.4B5.51B5.27B7.59B
Pre-Tax Margin3.9%4.7%2.8%2.1%2.8%
Income Tax Expense1.37B1.62B141M1.49B1.35B
Net Income5.37B6.7B5.16B3.43B5.96B
Net Margin3.1%3.7%2.6%1.4%2.2%
EPS (Basic)15.8921.6617.5712.2522.30
EPS (Diluted)15.7521.4117.3912.1222.17
Weighted Avg Shares337.96M313.07M296.88M280.29M265.95M
Weighted Avg Shares (Diluted)340.97M313.07M296.88M283.22M265.95M

Cigna Corporation

NYSE:CI

Intrinsic Alpha fair value

Locked

Current Price

$285.37

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.